SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE -- Ignore unavailable to you. Want to Upgrade?


To: robert miller who wrote (1553)7/26/1998 1:36:00 PM
From: John Arnopp  Read Replies (1) | Respond to of 4467
 
bob,

It's certainly plausible. Now that you remind me of the $60 target, I sure find that hard to see from here, but you never know...

I agree SFE should be able to bring any of their companies public through a rights offering, to add shareholder value. The companies that have gone through traditional IPO's have been those invested in by the VC partners (TLV, SCP), not Safeguard directly, like ICMT and FSI.

--John



To: robert miller who wrote (1553)7/27/1998 12:33:00 AM
From: ncs  Read Replies (1) | Respond to of 4467
 
To the extent the SFE sells shares in a potential ICG IPO they should ensure that SFE shareholders have rights in said IPO. However, it would suit me just find if SFE didn't participate in the IPO and just withheld their interest in ICG in an IPO. In that manner SFE could maintain it's 1/3 interest in the fund which should then be reflected in it's stock price. It doesn't make a lot of difference to me if Chas. Schawb holds my interest in ICG or if SFE does. But I would be greatly upset if SFE does sell off their shares and I don't get a chance to participate.

Incidently, I don't think the erosion in the stock price can reasonable be attributable to comments that current shareholders will not have an opportunity at ICG. Whether or not SFE sells its shares via rights offering or via IPO, the proceeds of same will still filter down to SFE's bottom line, or be reflected in the share of ICG which SFE retains.

Neil